These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 31291799)
1. Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia. Yonekura Collier AR; Zsengeller Z; Pernicone E; Salahuddin S; Khankin EV; Karumanchi SA Hypertens Pregnancy; 2019 Aug; 38(3):193-199. PubMed ID: 31291799 [TBL] [Abstract][Full Text] [Related]
2. Upregulation and release of soluble fms-like tyrosine kinase receptor 1 mediated by complement activation in human syncytiotrophoblast cells. Banadakoppa M; Balakrishnan M; Yallampalli C Am J Reprod Immunol; 2018 Nov; 80(5):e13033. PubMed ID: 30099798 [TBL] [Abstract][Full Text] [Related]
3. Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome. Burwick RM; Feinberg BB Am J Obstet Gynecol; 2022 Feb; 226(2S):S1059-S1070. PubMed ID: 32986992 [TBL] [Abstract][Full Text] [Related]
5. Complement activation by an angiogenic imbalance leads to systemic vascular endothelial dysfunction: A new proposal for the pathophysiology of preeclampsia. Matsuyama T; Tomimatsu T; Mimura K; Yagi K; Kawanishi Y; Kakigano A; Nakamura H; Endo M; Kimura T J Reprod Immunol; 2021 Jun; 145():103322. PubMed ID: 33887508 [TBL] [Abstract][Full Text] [Related]
6. Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. Fan X; Rai A; Kambham N; Sung JF; Singh N; Petitt M; Dhal S; Agrawal R; Sutton RE; Druzin ML; Gambhir SS; Ambati BK; Cross JC; Nayak NR J Clin Invest; 2014 Nov; 124(11):4941-52. PubMed ID: 25329693 [TBL] [Abstract][Full Text] [Related]
7. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia? Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808 [TBL] [Abstract][Full Text] [Related]
8. MIF Increases sFLT1 Expression in Early Uncomplicated Pregnancy and Preeclampsia. Yong Q; Dijkstra KL; van der Keur C; Bruijn JA; Eikmans M; Baelde HJ Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373198 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the PI3K-Akt pathway suppresses sFlt1 expression in human placental hypoxia models in vitro. Park JK; Jeong JW; Kang MY; Baek JC; Shin JK; Lee SA; Choi WS; Lee JH; Paik WY Placenta; 2010 Jul; 31(7):621-9. PubMed ID: 20488538 [TBL] [Abstract][Full Text] [Related]
10. Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome. Szabo S; Xu Y; Romero R; Fule T; Karaszi K; Bhatti G; Varkonyi T; Varkonyi I; Krenacs T; Dong Z; Tarca AL; Chaiworapongsa T; Hassan SS; Papp Z; Kovalszky I; Than NG Virchows Arch; 2013 Sep; 463(3):445-58. PubMed ID: 23807541 [TBL] [Abstract][Full Text] [Related]
11. [Predictive value of the sFlt1/PlGF ratio for the diagnosis of preeclampsia in high-risk patients]. Husse S; Gottschlich A; Schrey S; Stepan H; Hoffmann J Z Geburtshilfe Neonatol; 2014 Feb; 218(1):34-41. PubMed ID: 24595913 [TBL] [Abstract][Full Text] [Related]
13. Increased placental expression of Placental Protein 5 (PP5) / Tissue Factor Pathway Inhibitor-2 (TFPI-2) in women with preeclampsia and HELLP syndrome: Relevance to impaired trophoblast invasion? Karaszi K; Szabo S; Juhasz K; Kiraly P; Kocsis-Deak B; Hargitai B; Krenacs T; Hupuczi P; Erez O; Papp Z; Kovalszky I; Than NG Placenta; 2019 Jan; 76():30-39. PubMed ID: 30803712 [TBL] [Abstract][Full Text] [Related]
14. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. Maynard SE; Min JY; Merchan J; Lim KH; Li J; Mondal S; Libermann TA; Morgan JP; Sellke FW; Stillman IE; Epstein FH; Sukhatme VP; Karumanchi SA J Clin Invest; 2003 Mar; 111(5):649-58. PubMed ID: 12618519 [TBL] [Abstract][Full Text] [Related]
15. A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia. Sela S; Itin A; Natanson-Yaron S; Greenfield C; Goldman-Wohl D; Yagel S; Keshet E Circ Res; 2008 Jun; 102(12):1566-74. PubMed ID: 18515749 [TBL] [Abstract][Full Text] [Related]
16. Total bile acids in the maternal and fetal compartment in relation to placental ABCG2 expression in preeclamptic pregnancies complicated by HELLP syndrome. Jebbink J; Veenboer G; Boussata S; Keijser R; Kremer AE; Elferink RO; van der Post J; Afink G; Ris-Stalpers C Biochim Biophys Acta; 2015 Jan; 1852(1):131-6. PubMed ID: 25446997 [TBL] [Abstract][Full Text] [Related]
17. Seven placental transcripts characterize HELLP-syndrome. Buimer M; Keijser R; Jebbink JM; Wehkamp D; van Kampen AH; Boer K; van der Post JA; Ris-Stalpers C Placenta; 2008 May; 29(5):444-53. PubMed ID: 18374411 [TBL] [Abstract][Full Text] [Related]
18. Low-dose aspirin reduces hypoxia-induced sFlt1 release via the JNK/AP-1 pathway in human trophoblast and endothelial cells. Lin L; Li G; Zhang W; Wang YL; Yang H J Cell Physiol; 2019 Aug; 234(10):18928-18941. PubMed ID: 31004367 [TBL] [Abstract][Full Text] [Related]
19. Steroid sulfatase is increased in the placentas and whole blood of women with early-onset preeclampsia. Gratton AM; Ye L; Brownfoot FC; Hannan NJ; Whitehead C; Cannon P; Deo M; Fuller PJ; Tong S; Kaitu'u-Lino TJ Placenta; 2016 Dec; 48():72-79. PubMed ID: 27871476 [TBL] [Abstract][Full Text] [Related]
20. Activation of villous trophoblastic p38 and ERK1/2 signaling pathways in preterm preeclampsia and HELLP syndrome. Szabo S; Mody M; Romero R; Xu Y; Karaszi K; Mihalik N; Xu Z; Bhatti G; Fule T; Hupuczi P; Krenacs T; Rigo J; Tarca AL; Hassan SS; Chaiworapongsa T; Kovalszky I; Papp Z; Than NG Pathol Oncol Res; 2015 Jul; 21(3):659-68. PubMed ID: 25583406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]